ATE220899T1 - Zusammensetzung zur transdermalen wirkstoffabgabe - Google Patents

Zusammensetzung zur transdermalen wirkstoffabgabe

Info

Publication number
ATE220899T1
ATE220899T1 AT96934932T AT96934932T ATE220899T1 AT E220899 T1 ATE220899 T1 AT E220899T1 AT 96934932 T AT96934932 T AT 96934932T AT 96934932 T AT96934932 T AT 96934932T AT E220899 T1 ATE220899 T1 AT E220899T1
Authority
AT
Austria
Prior art keywords
composition
weight
skin
active delivery
transdermal active
Prior art date
Application number
AT96934932T
Other languages
English (en)
Inventor
Philippe Laurent
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Application granted granted Critical
Publication of ATE220899T1 publication Critical patent/ATE220899T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/01—Aerosol hair preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/02—Resin hair settings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT96934932T 1995-10-20 1996-10-17 Zusammensetzung zur transdermalen wirkstoffabgabe ATE220899T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9512393A FR2740038B1 (fr) 1995-10-20 1995-10-20 Composition pour l'administration transdermique
PCT/FR1996/001628 WO1997015295A1 (fr) 1995-10-20 1996-10-17 Composition pour l'administration transdermique

Publications (1)

Publication Number Publication Date
ATE220899T1 true ATE220899T1 (de) 2002-08-15

Family

ID=9483769

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96934932T ATE220899T1 (de) 1995-10-20 1996-10-17 Zusammensetzung zur transdermalen wirkstoffabgabe

Country Status (15)

Country Link
US (1) US6325990B1 (de)
EP (1) EP0855907B1 (de)
JP (1) JP2000500436A (de)
KR (1) KR100447034B1 (de)
CN (1) CN1165297C (de)
AT (1) ATE220899T1 (de)
AU (1) AU713474B2 (de)
DE (1) DE69622574T2 (de)
DK (1) DK0855907T3 (de)
ES (1) ES2179213T3 (de)
FR (1) FR2740038B1 (de)
HU (1) HU225105B1 (de)
NZ (1) NZ320337A (de)
PT (1) PT855907E (de)
WO (1) WO1997015295A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
JP2002523144A (ja) 1998-08-20 2002-07-30 スリーエム イノベイティブ プロパティズ カンパニー 包帯への噴霧および薬物送達システム
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
PL197492B1 (pl) 1999-07-02 2008-04-30 Lohmann Therapie Syst Lts Transdermalny system terapeutyczny zawierający warstwę polimerową z zawartymi w niej mikrozbiornikami i sposób wytwarzania błon
US6337076B1 (en) * 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
US6512072B1 (en) 2000-06-12 2003-01-28 Dow Corning Corporation Fast cure film forming formulation
US20040057907A1 (en) * 2002-09-23 2004-03-25 Leonard Mackles Dri-nasal sprays
FR2856301B1 (fr) * 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
BRPI0416311A (pt) * 2003-11-21 2006-12-26 Galderma Res & Dev composição, uso de uma composição e processo para melhorar a penetração de um agente ativo farmacêutico
FR2862540B1 (fr) * 2003-11-21 2007-03-30 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
FR2867682B1 (fr) * 2004-03-22 2009-06-05 Galderma Res & Dev Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
WO2005123091A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871697B1 (fr) 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
MXPA06014397A (es) * 2004-06-17 2007-02-15 Galderma Sa Composicion en forma de aerosol que comprende una combinacion de un corticoide y un derivado de la vitamina d en una fase aceitosa.
JP4723899B2 (ja) * 2005-04-26 2011-07-13 日光ケミカルズ株式会社 皮膚外用組成物
JP5612263B2 (ja) * 2005-06-01 2014-10-22 スティーフェル リサーチ オーストラリア ピーティーワイ リミテッド ビタミン製剤
FR2887150B1 (fr) * 2005-06-17 2007-08-03 Galderma Res & Dev Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
WO2007022090A2 (en) * 2005-08-13 2007-02-22 Collegium Pharmaceutical, Inc. Topical delivery with a carrier fluid
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
JP5185259B2 (ja) 2006-05-23 2013-04-17 ダウ・コーニング・コーポレイション 活性成分デリバリー用新規シリコーンフィルム形成剤
WO2008116004A2 (en) 2007-03-19 2008-09-25 Vita Sciences, Llc Transdermal patch and method for delivery of vitamin b12
WO2008128280A1 (en) * 2007-04-20 2008-10-30 Acrux Dds Pty Ltd Method and system for transdermal administration of volatile active
GB0919650D0 (en) * 2009-11-10 2009-12-23 Futura Medical Developments Ltd Pharmaceutical composition
WO2011061155A1 (en) 2009-11-17 2011-05-26 Bayer Consumer Care Ag Antifungal formulations and their use
WO2012150891A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Composition for administration of a pharmacologically or cosmetically active agent onto a surface of a living organism
KR101858835B1 (ko) * 2016-10-17 2018-05-17 이제후 에어로졸 제형의 스프레이 밴드용 조성물 및 그 제조방법
WO2022219063A1 (en) * 2021-04-15 2022-10-20 Philip Morris Products S.A. Substrate for delivering a biologically active substance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836647A (en) * 1970-10-22 1974-09-17 Dow Corning Wash-resistant skin preparation
GB2176813B (en) * 1985-06-06 1989-07-05 Procter & Gamble Hair styling mousse and method
US4902499A (en) * 1986-04-04 1990-02-20 The Procter & Gamble Company Hair care compositions containing a rigid silicone polymer
JP2627750B2 (ja) * 1987-09-17 1997-07-09 株式会社資生堂 エアゾール化粧料
JPH01230514A (ja) * 1987-11-25 1989-09-14 Osaka Aerosol Ind Corp エアゾール型外用貼付剤
US5658557A (en) * 1989-08-07 1997-08-19 The Procter & Gamble Company Hair care compositions comprising silicone-containing copolymers
FR2666962B1 (fr) * 1990-09-26 1996-06-14 Oreal Composition antifongique sous forme de spray sec.
FR2719220A1 (fr) * 1994-04-29 1995-11-03 Lafon Labor Nouvelle forme galénique pour l'administration transdermique.
WO1995030409A1 (en) * 1994-05-05 1995-11-16 Merck Frosst Canada Inc. Topical polymeric drug delivery system

Also Published As

Publication number Publication date
EP0855907A1 (de) 1998-08-05
KR100447034B1 (ko) 2004-12-23
ES2179213T3 (es) 2003-01-16
EP0855907B1 (de) 2002-07-24
CN1202819A (zh) 1998-12-23
HUP9802983A2 (hu) 1999-06-28
WO1997015295A1 (fr) 1997-05-01
NZ320337A (en) 1998-12-23
JP2000500436A (ja) 2000-01-18
DK0855907T3 (da) 2002-11-11
DE69622574D1 (de) 2002-08-29
CN1165297C (zh) 2004-09-08
PT855907E (pt) 2002-11-29
DE69622574T2 (de) 2002-12-19
FR2740038A1 (fr) 1997-04-25
KR19990064336A (ko) 1999-07-26
AU7306396A (en) 1997-05-15
HU225105B1 (en) 2006-06-28
FR2740038B1 (fr) 1998-01-02
HUP9802983A3 (en) 2000-06-28
US6325990B1 (en) 2001-12-04
AU713474B2 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
ATE220899T1 (de) Zusammensetzung zur transdermalen wirkstoffabgabe
KR900005969A (ko) 게스토덴을 함유하는 경피 투여용 제제
DK179688A (da) Transdermale terapeutiske systemer for kombinationer af aktive stoffer
NZ316026A (en) A transdermal therapeutic system (a hormone patch) in which drugs are contained which are released into the skin comprising a backing film and a pressure sensitive adhesive
NO931766L (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
NZ334149A (en) Pharmaceutical aerosol composition containing an active material, a propellant containing a hydrofluoroalkane and a cosolvent and a low volatility component
YU2694A (sh) Transdermalni terapeutski sistem za odavanje galantamina
NO20064395L (no) Anvendelse av buprenorfin i fremstilling av et medikament
SE9203743D0 (sv) Efficient use
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
NO993385D0 (no) Transdermalt terapeutisk system for avgivelse av hormoner
KR950028767A (ko) 피부통과 투약을 위한 신규의 약제학적 투여 형태
IL106512A (en) Plaster for the transdermal application of steroid hormones and process for the preparation thereof
AR246186A1 (es) Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
NO975140L (no) Transdermalt terapeutisk system (TTS) for administrasjon av testosteron
KR910021238A (ko) 켈로이드 치료제
HUP0003476A2 (hu) Eljárás transzdermális gyógyászati rendszer helytelen orális alkalmazásának megelőzésére és denaturáló anyagot tartalmazó transzdermális gyógyászati rendszer
MY129733A (en) A pharmaceutical preparation adhering to the skin, in particular a tts, for the release of 17-(beta) estradiol to the human organism
ATE278388T1 (de) Dosieraerosole mit isobutan als treibmittel
CA2235346A1 (en) Composition for transdermal delivery
KR920002137A (ko) 경피흡수용 스테로이드 호르몬 제제
MX9604426A (es) Reduccion de irritacion de la piel durante el surtido por electrotransporte.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee